{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T15:58:38Z","timestamp":1794239918455,"version":"4.9.0"},"reference-count":170,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Cachexia remains a major complication in cancer, with limited therapeutic options. Peroxisome proliferator-activated receptor gamma (PPAR\u03b3) has emerged as a key regulator of adipogenesis, lipid metabolism, and inflammation, but its role in cachexia is paradoxical. PPAR\u03b3 activation can promote lipid storage, suppress inflammation, and modulate muscle\u2013adipose crosstalk, potentially alleviating tissue wasting. Conversely, PPAR\u03b3 agonists may enhance tumor growth in certain cancers, raising safety concerns. This review examines the dual functions of PPAR\u03b3 in cancer cachexia, focusing on its regulation of adipose tissue remodeling (including browning and lipid metabolism), skeletal muscle homeostasis, and systemic inflammation, alongside tumor-promoting mechanisms that complicate its therapeutic use. Finally, emerging approaches such as selective PPAR\u03b3 modulators (SPPAR\u03b3Ms) and tissue-targeted strategies are discussed to maximize anti-cachectic effects while minimizing oncogenic risks. Understanding these context-dependent actions is essential for translating PPAR\u03b3 modulation into safe, effective cachexia therapies.<\/jats:p>","DOI":"10.3389\/fendo.2025.1717134","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T05:17:32Z","timestamp":1765862252000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["The role of PPAR\u03b3 in cancer cachexia: friend or foe?"],"prefix":"10.3389","volume":"16","author":[{"given":"Leili","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01454-0","article-title":"Cancer cachexia: molecular mechanisms and treatment strategies","volume":"16","author":"Setiawan","year":"2023","journal-title":"J Hematol Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: understanding the molecular basis","volume":"14","author":"Argil\u00e9s","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3390\/cells13030252","article-title":"Molecular mechanisms of cachexia: A review","volume":"13","author":"Neshan","year":"2024","journal-title":"Cells"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-024-01167-9","article-title":"Cancer cachexia: multilevel metabolic dysfunction","volume":"6","author":"Berriel Diaz","year":"2024","journal-title":"Nat Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.127042","article-title":"The global perspective on peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) in ectopic fat deposition: A review","volume":"253","author":"Qiu","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.12065","article-title":"The role of peroxisome proliferator-activated receptor \u03b3 in lipid metabolism and inflammation in atherosclerosis","volume":"47","author":"Yang","year":"2023","journal-title":"Cell Biol Int"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.155912","article-title":"Deciphering the molecular pathways of saroglitazar: A dual PPAR \u03b1\/\u03b3 agonist for managing metabolic NAFLD","volume":"155","author":"Ezhilarasan","year":"2024","journal-title":"Metabolism"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2015.11.004","article-title":"Fatty acids, eicosanoids and PPAR gamma","volume":"785","author":"Marion-Letellier","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e14167","DOI":"10.1111\/apha.14167","article-title":"Restoring adiponectin via rosiglitazone ameliorates tissue wasting in mice with lung cancer","volume":"240","author":"Langer","year":"2024","journal-title":"Acta Physiol (Oxf)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.687491","article-title":"Preclinical investigation of alpinetin in the treatment of cancer-induced cachexia via activating PPAR\u03b3","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Pharmacol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.3390\/nu16213671","article-title":"Amelioration of cancer cachexia by dalbergia odorifera extract through AKT signaling pathway regulation","volume":"16","author":"Ho","year":"2024","journal-title":"Nutrients"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1601571113","article-title":"Sleeping Beauty screen reveals Pparg activation in metastatic prostate cancer","volume":"113","author":"Ahmad","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B15","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3390\/biom14020190","article-title":"PPAR\u03b3 Modulators in lung cancer: molecular mechanisms, clinical prospects, and challenges","volume":"14","author":"Zhang","year":"2024","journal-title":"Biomolecules"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.17.7921","article-title":"Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms","volume":"92","author":"Zhu","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90006-x","article-title":"Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor","volume":"79","author":"Tontonoz","year":"1994","journal-title":"Cell"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nature07413","article-title":"Structure of the intact PPAR-gamma-RXR- nuclear receptor complex on DNA","volume":"456","author":"Chandra","year":"2008","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2004.03.012","article-title":"Peroxisome proliferator-activated receptor gamma in diabetes and metabolism","volume":"25","author":"Rangwala","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1172\/jci119424","article-title":"Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids","volume":"99","author":"Vidal-Puig","year":"1997","journal-title":"J Clin Invest"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R100034200","article-title":"PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth","volume":"276","author":"Rosen","year":"2001","journal-title":"J Biol Chem"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.20.5.0380","article-title":"Peroxisome proliferator-activated receptors: nuclear control of metabolism","volume":"20","author":"Desvergne","year":"1999","journal-title":"Endocr Rev"},{"key":"B23","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.tem.2014.04.001","article-title":"PPAR\u03b3 and the global map of adipogenesis and beyond","volume":"25","author":"Lefterova","year":"2014","journal-title":"Trends Endocrinol Metab"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh657","article-title":"Inhibition of IL-10-induced STAT3 activation by 15-deoxy-delta12,14-prostaglandin J2","volume":"44","author":"Ji","year":"2005","journal-title":"Rheumatol (Oxford)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.15.7355","article-title":"Differential expression and activation of a family of murine peroxisome proliferator-activated receptors","volume":"91","author":"Kliewer","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.22.12953","article-title":"An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)","volume":"270","author":"Lehmann","year":"1995","journal-title":"J Biol Chem"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24784","article-title":"Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice","volume":"126","author":"Asp","year":"2010","journal-title":"Int J Cancer"},{"key":"B28","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1210\/er.2002-0012","article-title":"Peroxisome proliferator-activated receptor-\u03b3 coactivator 1\u03b1 (PGC-1\u03b1): transcriptional coactivator and metabolic regulator","volume":"24","author":"Puigserver","year":"2003","journal-title":"Endocrine Rev"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1101\/gad.14.2.121","article-title":"The coregulator exchange in transcriptional functions\u00a0of nuclear receptors","volume":"14","author":"Glass","year":"2000","journal-title":"Genes Dev"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3159","article-title":"PPAR\u03b3 signaling and metabolism: the good, the bad and the future","volume":"19","author":"Ahmadian","year":"2013","journal-title":"Nat Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/nature03988","article-title":"A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma","volume":"437","author":"Pascual","year":"2005","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev.biochem.77.061307.091829","article-title":"Fat and beyond: the diverse biology of PPARgamma","volume":"77","author":"Tontonoz","year":"2008","journal-title":"Annu Rev Biochem"},{"key":"B33","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nri1748","article-title":"Combinatorial roles of nuclear receptors in inflammation and immunity","volume":"6","author":"Glass","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/34178","article-title":"The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation","volume":"391","author":"Ricote","year":"1998","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2007.06.010","article-title":"PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties","volume":"6","author":"Bouhlel","year":"2007","journal-title":"Cell Metab"},{"key":"B36","doi-asserted-by":"publisher","first-page":"8056","DOI":"10.3390\/ijms21218056","article-title":"PPARs and microbiota in skeletal\u00a0muscle\u00a0health and wasting","volume":"21","author":"Manickam","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddad055","article-title":"Breast cancer cell-derived exosome-delivered microRNA-155 targets UBQLN1 in adipocytes and facilitates cancer cachexia-related fat loss","volume":"32","author":"Sun","year":"2023","journal-title":"Hum Mol Genet"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110346","article-title":"Exosomal miRNA 16-5p\/29a-3p from pancreatic cancer induce adipose atrophy by inhibiting adipogenesis and promoting lipolysis","volume":"27","author":"Tien","year":"2024","journal-title":"iScience"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1126\/science.1198973","article-title":"Adipose triglyceride lipase contributes to cancer-associated cachexia","volume":"333","author":"Das","year":"2011","journal-title":"Science"},{"key":"B40","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1186\/s12967-024-05266-9","article-title":"Extracellular vesicles in cancer cachexia: deciphering pathogenic roles and exploring therapeutic horizons","volume":"22","author":"Wang","year":"2024","journal-title":"J Transl Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2021.0220","article-title":"Exosomal miR-155 from gastric cancer induces cancer-associated cachexia by suppressing adipogenesis and promoting brown adipose differentiation via C\/EPB\u03b2","volume":"19","author":"Liu","year":"2022","journal-title":"Cancer Biol Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2008.00916.x","article-title":"Regulation of adipose triglyceride lipase by rosiglitazone","volume":"11","author":"Liu","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.12.11.18134","article-title":"Rosiglitazone delayed weight loss and anorexia while attenuating adipose depletion in mice with cancer cachexia","volume":"12","author":"Asp","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"B44","doi-asserted-by":"publisher","first-page":"10.1515\/hmbci-2016-0051","DOI":"10.1515\/hmbci-2016-0051","article-title":"Browning\u00a0of white adipose tissue: lessons from experimental models","volume":"31","author":"Bargut","year":"2017","journal-title":"Horm Mol\u00a0Biol\u00a0Clin Investig"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.053942","article-title":"Chronic peroxisome proliferator-activated receptor gamma (PPARgamma) activation of epididymally derived white adipocyte cultures reveals a population of thermogenically competent, UCP1-containing adipocytes molecularly distinct from classic brown adipocytes","volume":"285","author":"Petrovic","year":"2010","journal-title":"J Biol Chem"},{"key":"B46","doi-asserted-by":"publisher","first-page":"13","DOI":"10.21037\/apm.2018.10.01","article-title":"Lipid metabolism in cancer cachexia","volume":"8","author":"Dalal","year":"2019","journal-title":"Ann Palliat Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2014.06.011","article-title":"A switch from white to brown fat increases energy expenditure in cancer-associated cachexia","volume":"20","author":"Petruzzelli","year":"2014","journal-title":"Cell Metab"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.848394","article-title":"Metabolic reprogramming in adipose tissue during cancer cachexia","volume":"12","author":"Weber","year":"2022","journal-title":"Front Oncol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1123567","article-title":"Abnormal lipid metabolism in cancer-associated cachexia and potential therapy strategy","volume":"13","author":"Fang","year":"2023","journal-title":"Front Oncol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e92966","DOI":"10.1371\/journal.pone.0092966","article-title":"Depletion of white adipose tissue in cancer cachexia syndrome is associated with inflammatory signaling and disrupted circadian regulation","volume":"9","author":"Tsoli","year":"2014","journal-title":"PloS One"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.624112","article-title":"PPARgamma in metabolism, immunity, and cancer: unified and diverse mechanisms of action","volume":"12","author":"Hernandez-Quiles","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B52","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3390\/ph17060790","article-title":"White-to-beige and back: Adipocyte conversion and transcriptional reprogramming","volume":"17","author":"Boychenko","year":"2024","journal-title":"Pharmaceuticals"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.70","article-title":"Induction of thermogenic adipocytes: molecular targets and thermogenic small molecules","volume":"49","author":"Song","year":"2017","journal-title":"Exp Mol Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"100964","DOI":"10.1016\/j.molmet.2020.02.007","article-title":"PPAR\u03b3 and PPAR\u03b1 synergize to induce robust browning of white fat in vivo","volume":"36","author":"Kroon","year":"2020","journal-title":"Mol Metab"},{"key":"B55","doi-asserted-by":"publisher","first-page":"4754","DOI":"10.3390\/cancers14194754","article-title":"Adipose tissue wasting as a determinant of pancreatic cancer-related cachexia","volume":"14","author":"Yu","year":"2022","journal-title":"Cancers"},{"key":"B56","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.cmet.2012.01.019","article-title":"PPAR\u03b3 agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein","volume":"15","author":"Ohno","year":"2012","journal-title":"Cell Metab"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/nu6115280","article-title":"Evidence and mechanisms of fat depletion in cancer","volume":"6","author":"Ebadi","year":"2014","journal-title":"Nutrients"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1530\/joe-12-0307","article-title":"Heterogeneous time-dependent response of adipose tissue during the development of cancer cachexia","volume":"215","author":"Batista","year":"2012","journal-title":"J Endocrinol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cell.2013.12.012","article-title":"What we talk about when we talk about fat","volume":"156","author":"Rosen","year":"2014","journal-title":"Cell"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.11.026","article-title":"The many faces of PPARgamma","volume":"123","author":"Lehrke","year":"2005","journal-title":"Cell"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3892\/or.19.1.253","article-title":"Effects of the PPARgamma agonist GW1929 on muscle wasting in tumour-bearing mice","volume":"19","author":"Moore-Carrasco","year":"2008","journal-title":"Oncol Rep"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/nature08991","article-title":"Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK\/SIRT1","volume":"464","author":"Iwabu","year":"2010","journal-title":"Nature"},{"key":"B63","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/21623945.2017.1402151","article-title":"Adiponectin-leptin ratio: A promising index to estimate adipose tissue dysfunction. Relation with obesity-associated cardiometabolic risk","volume":"7","author":"Fr\u00fchbeck","year":"2018","journal-title":"Adipocyte"},{"key":"B64","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.jshs.2021.06.002","article-title":"Exercise attenuates angiotensinII-induced muscle atrophy by targeting PPAR\u03b3\/miR-29b","volume":"11","author":"Liu","year":"2022","journal-title":"J Sport Health Sci"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.90632.2008","article-title":"PPARgamma inhibits NF-kappaB-dependent transcriptional activation in skeletal muscle","volume":"297","author":"Remels","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13336","article-title":"Stimulator of interferon genes promotes diabetic sarcopenia by targeting peroxisome proliferator activated receptors \u03b3 degradation and inhibiting fatty acid oxidation","volume":"14","author":"Yan","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2020.12.015","article-title":"Angiotensin II-induced muscle atrophy via PPAR\u03b3 suppression is mediated by miR-29b","volume":"23","author":"Li","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e2301519","DOI":"10.1002\/advs.202301519","article-title":"Muscle injuries induce a prostacyclin-PPAR\u03b3\/PGC1a-FAO spike that boosts regeneration","volume":"10","author":"Luo","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx815","article-title":"Insulin resistance and body composition in cancer patients","volume":"29","author":"Dev","year":"2018","journal-title":"Ann Oncol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1186\/s40170-024-00332-8","article-title":"Systemic inflammation and insulin resistance-related indicator predicts poor outcome in patients with cancer cachexia","volume":"12","author":"Ruan","year":"2024","journal-title":"Cancer Metab"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2013.12.005","article-title":"Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia","volume":"30","author":"Trobec","year":"2014","journal-title":"Nutrition"},{"key":"B72","doi-asserted-by":"publisher","first-page":"C577","DOI":"10.1152\/ajpcell.00264.2020","article-title":"Breast cancer-associated skeletal muscle mitochondrial dysfunction and lipid accumulation is reversed by PPARG","volume":"320","author":"Wilson","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"e2466","DOI":"10.1371\/journal.pone.0002466","article-title":"Pioglitazone enhances mitochondrial biogenesis and ribosomal protein biosynthesis in skeletal muscle in polycystic ovary syndrome","volume":"3","author":"Skov","year":"2008","journal-title":"PloS One"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13073","article-title":"Molecular mechanisms of cancer cachexia-related loss of skeletal muscle mass: data analysis from preclinical and clinical studies","volume":"14","author":"Martin","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B75","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cyto.2011.10.008","article-title":"Adipose tissue inflammation and cancer cachexia: possible role of nuclear transcription factors","volume":"57","author":"Batista","year":"2012","journal-title":"Cytokine"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1608612","article-title":"Unraveling the role of STAT3 in Cancer Cachexia: pathogenic mechanisms and therapeutic opportunities","volume":"16","author":"Lv","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.33549\/physiolres.935046","article-title":"Research progress into adipose tissue macrophages and insulin resistance","volume":"72","author":"Fu","year":"2023","journal-title":"Physiol Res"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.10.016","article-title":"Macrophage PPAR\u03b3, a lipid activated transcription factor controls the growth factor GDF3 and skeletal muscle regeneration","volume":"45","author":"Varga","year":"2016","journal-title":"Immunity"},{"key":"B79","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s13105-016-0523-3","article-title":"PPAR\u03b3 regulates inflammatory reaction by inhibiting the MAPK\/NF-\u03baB pathway in C2C12 skeletal muscle cells","volume":"73","author":"Kim","year":"2017","journal-title":"J Physiol Biochem"},{"key":"B80","doi-asserted-by":"publisher","first-page":"9775","DOI":"10.3390\/ijms22189775","article-title":"The regulatory roles of PPARs in skeletal muscle fuel metabolism and inflammation: impact of PPAR agonism on muscle in chronic disease, contraction and sepsis","volume":"22","author":"Crossland","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B81","doi-asserted-by":"publisher","first-page":"e13742","DOI":"10.1002\/jcsm.13742","article-title":"Cachexia alters central nervous system morphology and functionality in cancer patients","volume":"16","author":"Simoes","year":"2025","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2025.114909","article-title":"The role of the hypothalamus in the development of cancer cachexia","volume":"295","author":"Stagikas","year":"2025","journal-title":"Physiol Behav"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/864140","article-title":"Regulation of glial cell functions by PPAR-gamma natural and synthetic agonists","volume":"2008","author":"Bernardo","year":"2008","journal-title":"PPAR Res"},{"key":"B84","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2174\/138161206780574579","article-title":"PPAR-gamma agonists as regulators of microglial activation and brain inflammation","volume":"12","author":"Bernardo","year":"2006","journal-title":"Curr Pharm Des"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2332","article-title":"Brain PPAR-\u03b3 promotes obesity and is required for the insulin-sensitizing effect of thiazolidinediones","volume":"17","author":"Lu","year":"2011","journal-title":"Nat Med"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2349","article-title":"A role for central nervous system PPAR-\u03b3 in the regulation of energy balance","volume":"17","author":"Ryan","year":"2011","journal-title":"Nat Med"},{"key":"B87","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.3390\/ijms20205068","article-title":"PPAR\u03b3 and cognitive performance","volume":"20","author":"d\u2019Angelo","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/658520","article-title":"PPAR regulation of inflammatory signaling in CNS diseases","volume":"2008","author":"Bright","year":"2008","journal-title":"PPAR Res"},{"key":"B89","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12974-024-03173-w","article-title":"PPAR\u03b3 activation ameliorates cognitive impairment and chronic microglial activation in the aftermath of r-mTBI","volume":"21","author":"Pearson","year":"2024","journal-title":"J Neuroinflammation"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1530\/joe-15-0170","article-title":"Molecular and neuroendocrine mechanisms of cancer cachexia","volume":"226","author":"Mendes","year":"2015","journal-title":"J Endocrinol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.3390\/ijms26093952","article-title":"Hallmarks of cancer cachexia: sexual dimorphism in related pathways","volume":"26","author":"Satari","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1097\/SPC.0b013e32833e48e7","article-title":"Neuropeptides in the pathophysiology and treatment of cachexia","volume":"4","author":"Krasnow","year":"2010","journal-title":"Curr Opin Support Palliat Care"},{"key":"B93","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/mco.0000000000000401","article-title":"The role of hypothalamic inflammation, the hypothalamic-pituitary-adrenal axis and serotonin in the cancer anorexia-cachexia syndrome","volume":"20","author":"van Norren","year":"2017","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"B94","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13041-024-01091-9","article-title":"Peripheral-central network analysis of cancer cachexia status accompanied by the polarization of hypothalamic microglia with low expression of inhibitory immune checkpoint receptors","volume":"17","author":"Suda","year":"2024","journal-title":"Mol Brain"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1002\/glia.23796","article-title":"Microglia in the hypothalamus respond to tumor-derived factors and are protective against cachexia during pancreatic cancer","volume":"68","author":"Burfeind","year":"2020","journal-title":"Glia"},{"key":"B96","doi-asserted-by":"publisher","first-page":"e70081","DOI":"10.1111\/cns.70081","article-title":"The neuroprotective mechanisms of PPAR-\u03b3: inhibition of microglia-mediated neuroinflammation and oxidative stress in a neonatal mouse model of hypoxic-ischemic white matter injury","volume":"30","author":"Fang","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106210","article-title":"The role of JAK\/STAT signaling pathway and its inhibitors in diseases","volume":"80","author":"Xin","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.3390\/cancers15051407","article-title":"Unveiling the role of the proton gateway, uncoupling proteins (UCPs), in cancer cachexia","volume":"15","author":"Joshi","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-024-00992-y","article-title":"AMPK as a mediator of tissue preservation: time for a shift in dogma","volume":"20","author":"Langer","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2023.06.020","article-title":"Development of a peptide drug restoring AMPK and adipose tissue functionality in cancer cachexia","volume":"31","author":"Ji","year":"2023","journal-title":"Mol Ther"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.62556","article-title":"Berberine modulates deacetylation of PPAR\u03b3 to promote adipose tissue remodeling and thermogenesis via AMPK\/SIRT1 pathway","volume":"17","author":"Xu","year":"2021","journal-title":"Int J Biol Sci"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1111\/febs.12253","article-title":"Mechanisms regulating skeletal muscle growth and atrophy","volume":"280","author":"Schiaffino","year":"2013","journal-title":"FEBS J"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00410.2012","article-title":"Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK","volume":"304","author":"White","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B104","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12943-025-02320-y","article-title":"The anti-diabetic PPAR\u03b3 agonist Pioglitazone inhibits cell proliferation and induces metabolic reprogramming in prostate cancer","volume":"24","author":"Atas","year":"2025","journal-title":"Mol Cancer"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100843","article-title":"Loss of hepatic FTCD promotes lipid accumulation and hepatocarcinogenesis by upregulating PPAR\u03b3 and SREBP2","volume":"5","author":"Wang","year":"2023","journal-title":"JHEP Rep"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2005.05.004","article-title":"Metabolic control through the PGC-1 family of transcription coactivators","volume":"1","author":"Lin","year":"2005","journal-title":"Cell Metab"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2010.09.019","article-title":"Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network","volume":"1813","author":"Scarpulla","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1038\/nature07206","article-title":"The role of exercise and PGC1alpha in inflammation and chronic disease","volume":"454","author":"Handschin","year":"2008","journal-title":"Nature"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1172\/jci27794","article-title":"PGC-1 coactivators: inducible regulators of energy metabolism in health and disease","volume":"116","author":"Finck","year":"2006","journal-title":"J Clin Invest"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00300.2010","article-title":"Muscle oxidative capacity during IL-6-dependent cancer cachexia","volume":"300","author":"White","year":"2011","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1186\/2044-5040-2-14","article-title":"IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin\/+ mouse","volume":"2","author":"White","year":"2012","journal-title":"Skelet Muscle"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12232","article-title":"Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice","volume":"8","author":"Brown","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1038\/nm1025","article-title":"PPARs and the complex journey to obesity","volume":"10","author":"Evans","year":"2004","journal-title":"Nat Med"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1038\/35013000","article-title":"Roles of PPARs in health and disease","volume":"405","author":"Kersten","year":"2000","journal-title":"Nature"},{"key":"B115","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41467-024-44924-w","article-title":"Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia in mice","volume":"15","author":"Yang","year":"2024","journal-title":"Nat Commun"},{"key":"B116","doi-asserted-by":"publisher","first-page":"e294","DOI":"10.1371\/journal.pbio.0020294","article-title":"Regulation of muscle fiber type and running endurance by PPARdelta","volume":"2","author":"Wang","year":"2004","journal-title":"PloS Biol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-07-0231","article-title":"Are peroxisome proliferator-activated receptors involved in skeletal muscle wasting during experimental cancer cachexia? Role of beta2-adrenergic agonists","volume":"67","author":"Fuster","year":"2007","journal-title":"Cancer Res"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1101\/gad.9.9.1033","article-title":"LXR, a nuclear receptor that defines a distinct retinoid response pathway","volume":"9","author":"Willy","year":"1995","journal-title":"Genes Dev"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1000585","article-title":"Liver X receptors inhibit macrophage proliferation through downregulation of cyclins D1 and B1 and cyclin-dependent kinases 2 and 4","volume":"186","author":"Pascual-Garc\u00eda","year":"2011","journal-title":"J Immunol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-006-0140-8","article-title":"Activation of liver X receptors promotes lipid accumulation but does not alter insulin action in human skeletal muscle cells","volume":"49","author":"Cozzone","year":"2006","journal-title":"Diabetologia"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2020.100933","article-title":"Lipid metabolism in colon cancer: Role of Liver X Receptor (LXR) and Stearoyl-CoA Desaturase 1 (SCD1)","volume":"78","author":"Piccinin","year":"2021","journal-title":"Mol Aspects Med"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M206681200","article-title":"Regulation of cholesterol homeostasis and lipid metabolism in skeletal muscle by liver X receptors","volume":"277","author":"Muscat","year":"2002","journal-title":"J Biol Chem"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100814","article-title":"Heterodimer formation with retinoic acid receptor RXR\u03b1 modulates coactivator recruitment by peroxisome proliferator-activated receptor PPAR\u03b3","volume":"297","author":"Kilu","year":"2021","journal-title":"J Biol Chem"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1021\/jm980621r","article-title":"Synthesis of retinoid X receptor-specific ligands that are potent inducers of adipogenesis in 3T3-L1 cells","volume":"42","author":"Canan Koch","year":"1999","journal-title":"J Med Chem"},{"key":"B125","doi-asserted-by":"publisher","first-page":"e4907","DOI":"10.1371\/journal.pone.0004907","article-title":"De-novo identification of PPARgamma\/RXR binding sites and direct targets during adipogenesis","volume":"4","author":"Hamza","year":"2009","journal-title":"PloS One"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1101\/gad.501108","article-title":"Genome-wide profiling of PPARgamma: RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis","volume":"22","author":"Nielsen","year":"2008","journal-title":"Genes Dev"},{"key":"B127","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1749-6632.2002.tb04264.x","article-title":"Free fatty acid metabolism in human skeletal muscle is regulated by PPARgamma and RXR agonists","volume":"967","author":"Ciaraldi","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1007\/s001250051642","article-title":"Peroxisome proliferator-activated receptor (PPAR) gamma and retinoid X receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle","volume":"44","author":"Cha","year":"2001","journal-title":"Diabetologia"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1096\/fj.13-230375","article-title":"Cancer- and endotoxin-induced cachexia require intact glucocorticoid signaling in skeletal muscle","volume":"27","author":"Braun","year":"2013","journal-title":"FASEB J"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2014.06.028","article-title":"Involvement of glucocorticoid receptor activation on anti-inflammatory effect induced by peroxisome proliferator-activated receptor \u03b3 agonist in mice","volume":"22","author":"Yamamoto","year":"2014","journal-title":"Int Immunopharmacol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s11658-024-00559-9","article-title":"Effects of mifepristone on adipocyte differentiation in mouse 3T3-L1 cells","volume":"29","author":"Hashimoto","year":"2024","journal-title":"Cell Mol Biol Lett"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.737776","article-title":"PPAR-\u03b3 Modulators as current and potential cancer treatments","volume":"11","author":"Chi","year":"2021","journal-title":"Front Oncol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41420-021-00635-5","article-title":"Epigenetic derepression converts PPAR\u03b3 into a druggable target in triple-negative and endocrine-resistant breast cancers","volume":"7","author":"Loo","year":"2021","journal-title":"Cell Death Discov"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3214","article-title":"The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention","volume":"12","author":"Peters","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.26225","article-title":"Pioglitazone inhibits cancer cell growth through STAT3 inhibition and enhanced AIF expression via a PPAR\u03b3-independent pathway","volume":"233","author":"Tsubaki","year":"2018","journal-title":"J Cell Physiol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1113\/ep088011","article-title":"Long non-coding RNA PRRT3-AS1 silencing inhibits prostate cancer cell proliferation and promotes apoptosis and autophagy","volume":"105","author":"Fan","year":"2020","journal-title":"Exp Physiol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2008.08.037","article-title":"PPARgamma agonists attenuate proliferation and modulate Wnt\/beta-catenin signalling in melanoma cells","volume":"41","author":"Smith","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.11371","article-title":"Ligand-activated PPAR\u03b3 downregulates CXCR4 gene expression through a novel identified PPAR response element and inhibits breast cancer progression","volume":"7","author":"Rovito","year":"2016","journal-title":"Oncotarget"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-022-02096-8","article-title":"The role of PPAR\u03b3 in prostate cancer development and progression","volume":"128","author":"Hartley","year":"2023","journal-title":"Br J Cancer"},{"key":"B140","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3390\/molecules23010121","article-title":"VSP-17, a new PPAR\u03b3 Agonist, suppresses the metastasis of triple-negative breast cancer via upregulating the expression of E-cadherin","volume":"23","author":"Wang","year":"2018","journal-title":"Molecules"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.2147\/cmar.S236301","article-title":"Free fatty acids promote the development of prostate cancer by upregulating peroxisome proliferator-activated receptor gamma","volume":"12","author":"Ha","year":"2020","journal-title":"Cancer Manag Res"},{"key":"B142","doi-asserted-by":"publisher","first-page":"5055","DOI":"10.3390\/ijms20205055","article-title":"Exploration and development of PPAR modulators in health and disease: an update of clinical evidence","volume":"20","author":"Cheng","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2019.12.129","article-title":"Curcumin exerts anti-tumor effects on diffuse large B cell lymphoma via regulating PPAR\u03b3 expression","volume":"524","author":"Zhang","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"B144","doi-asserted-by":"publisher","first-page":"e0122660","DOI":"10.1371\/journal.pone.0122660","article-title":"Pioglitazone treatment increases survival and prevents body weight loss in tumor-bearing animals: possible anti-cachectic effect","volume":"10","author":"Beluzi","year":"2015","journal-title":"PloS One"},{"key":"B145","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.lfs.2016.12.016","article-title":"Pioglitazone improves insulin sensitivity and reduces weight loss in Walker-256 tumor-bearing rats","volume":"171","author":"de Fatima Silva","year":"2017","journal-title":"Life Sci"},{"key":"B146","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.3390\/cancers16213640","article-title":"Preclinical multi-omic assessment of pioglitazone in skeletal muscles of mice implanted with human HER2\/neu overexpressing breast cancer xenografts","volume":"16","author":"Clayton","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2007.01.016","article-title":"Oral pioglitazone administration increases food intake through ghrelin-independent pathway in Zucker fatty rat","volume":"77","author":"Saitoh","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-1600","article-title":"Effect of pioglitazone on energy intake and ghrelin in diabetic patients","volume":"33","author":"Martin","year":"2010","journal-title":"Diabetes Care"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/642848","article-title":"Combination of telmisartan with cisplatin controls oral cancer cachexia in rats","volume":"2013","author":"Patel","year":"2013","journal-title":"BioMed Res Int"},{"key":"B150","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.lfs.2016.04.029","article-title":"Evaluation of role of telmisartan in combination with 5-fluorouracil in gastric cancer cachexia","volume":"154","author":"Sukumaran","year":"2016","journal-title":"Life Sci"},{"key":"B151","doi-asserted-by":"publisher","first-page":"e95229","DOI":"10.7554\/eLife.95229","article-title":"Senescent cells inhibit mouse myoblast differentiation via the SASP-lipid 15d-PGJ(2) mediated modification and control of HRas","volume":"13","author":"Pundlik","year":"2024","journal-title":"Elife"},{"key":"B152","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.3390\/cells11152432","article-title":"Peroxisome proliferator-activated receptors and the hallmarks of cancer","volume":"11","author":"Wagner","year":"2022","journal-title":"Cells"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2005.04.5724","article-title":"Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia","volume":"24","author":"Fearon","year":"2006","journal-title":"J Clin Oncol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"Cd004597","DOI":"10.1002\/14651858.CD004597.pub2","article-title":"Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia","volume":"2007","author":"Dewey","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1016\/j.nutres.2022.09.009","article-title":"Omega-3 polyunsaterated fatty acids improve quality of life and survival, but not body weight in cancer cachexia: A systematic review and meta-analysis of controlled trials","volume":"107","author":"Jin","year":"2022","journal-title":"Nutr Res"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603360","article-title":"Adipose atrophy in cancer cachexia: morphologic and molecular analysis of adipose tissue in tumour-bearing mice","volume":"95","author":"Bing","year":"2006","journal-title":"Br J Cancer"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/314974","article-title":"A role for the PPARgamma in cancer therapy","volume":"2008","author":"Campbell","year":"2008","journal-title":"PPAR Res"},{"key":"B158","doi-asserted-by":"publisher","first-page":"e5326","DOI":"10.1002\/bmc.5326","article-title":"Quantification of rosiglitazone in rat plasma and tissues via LC-MS\/MS: Method development, validation, and application in pharmacokinetic and tissue distribution studies","volume":"36","author":"Garikapati","year":"2022","journal-title":"BioMed Chromatogr"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1039\/d1ra01126j","article-title":"Development and validation of a sensitive LC-MS\/MS method for pioglitazone: application towards pharmacokinetic and tissue distribution study in rats","volume":"11","author":"Garikapati","year":"2021","journal-title":"RSC Adv"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1002\/jps.24378","article-title":"Kinetics of the absorption, distribution, metabolism, and excretion of lobeglitazone, a novel activator of peroxisome proliferator-activated receptor gamma in rats","volume":"104","author":"Lee","year":"2015","journal-title":"J Pharm Sci"},{"key":"B161","doi-asserted-by":"publisher","first-page":"16837","DOI":"10.1038\/s41598-017-17082-x","article-title":"Structures of PPAR\u03b3 complexed with lobeglitazone and pioglitazone reveal key determinants for the recognition of antidiabetic drugs","volume":"7","author":"Lee","year":"2017","journal-title":"Sci Rep"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-2480","article-title":"Can a selective PPAR\u03b3 modulator improve glycemic control in patients with type 2 diabetes with fewer side effects compared with pioglitazone","volume":"37","author":"DePaoli","year":"2014","journal-title":"Diabetes Care"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/936906","article-title":"The development of INT131 as a selective PPARgamma modulator: approach to a safer insulin sensitizer","volume":"2008","author":"Higgins","year":"2008","journal-title":"PPAR Res"},{"key":"B164","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.actbio.2020.10.009","article-title":"Polymeric nanoparticles functionalized with muscle-homing peptides for targeted delivery of phosphatase and tensin homolog inhibitor to skeletal muscle","volume":"118","author":"Huang","year":"2020","journal-title":"Acta Biomater"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2024.04.029","article-title":"Adipocyte-targeted delivery of rosiglitazone with localized photothermal therapy for the treatment of diet-induced obesity in mice","volume":"181","author":"Zhang","year":"2024","journal-title":"Acta Biomater"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2020.10.002","article-title":"A novel dual-targeted rosiglitazone-loaded nanoparticle for the prevention of diet-induced obesity via the browning of white adipose tissue","volume":"329","author":"Hiradate","year":"2021","journal-title":"J Control Release"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-387817-5.00040-6","article-title":"LiverTox: a website on drug-induced liver injury","author":"Hoofnagle","year":"2013","journal-title":"Drug-induced liver disease. Elsevier;"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2005.08.001","article-title":"Fluid retention mediated by renal PPARgamma","volume":"2","author":"Staels","year":"2005","journal-title":"Cell Metab"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199803263381314","article-title":"Hepatic dysfunction associated with troglitazone","volume":"338","author":"Watkins","year":"1998","journal-title":"N Engl J Med"},{"key":"B170","doi-asserted-by":"crossref","DOI":"10.1101\/2025.09.17.25336028","volume-title":"Multimodal AI-driven Biomarker for Early Detection of Cancer Cachexia","author":"Ahmed","year":"2025"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1717134\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T05:17:34Z","timestamp":1765862254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1717134\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":170,"alternative-id":["10.3389\/fendo.2025.1717134"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1717134","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,16]]},"article-number":"1717134"}}